Screening for Familial Medullary Thyroid Carcinoma: a Review

Overview

Journal J R Soc Med

Specialty General Medicine

Date 1984 Jul 1

PMID 6747984

Citations 4

Authors

B A Ponder

Affiliations

Soon will be listed here.

Citing Articles

Medullary Thyroid Cancer: An Experience from a Tertiary Care Hospital of a Developing Country.

Khan S, Aziz A, Esbhani U, Masood M Indian J Endocrinol Metab. 2022; 26(1):68-72.

PMID: 35662760 PMC: 9162258. DOI: 10.4103/ijem.ijem_474_21.

The influence of phospholipid membranes on bovine calcitonin secondary structure and amyloid formation.

Wang S, Good T, Rymer D Protein Sci. 2005; 14(6):1419-28.

PMID: 15883181 PMC: 2253368. DOI: 10.1110/ps.041240105.

Linkage analysis of hereditary thyroid carcinoma with and without pheochromocytoma.

Narod S, Sobol H, Nakamura Y, Calmettes C, Baulieu J, Bigorgne J Hum Genet. 1989; 83(4):353-8.

PMID: 2572534 DOI: 10.1007/BF00291380.

[Progress in the diagnosis and therapy of C cell carcinoma of the thyroid gland].

Frilling A, Goretzki P, Roher H Langenbecks Arch Chir. 1990; 375(6):333-9.

PMID: 2280648 DOI: 10.1007/BF00185215.

References

STEWART B, Bravo E, Haaga J, MEANEY T, Tarazi R . Localization of pheochromocytoma by computed tomography. N Engl J Med. 1978; 299(9):460-1. DOI: 10.1056/NEJM197808312990907. View

Wells Jr S, Baylin S, Linehan W, Farrell R, Cox E, Cooper C . Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg. 1978; 188(2):139-41. PMC: 1396745. DOI: 10.1097/00000658-197808000-00002. View

Wells Jr S, Baylin S, GANN D, Farrell R, Dilley W, Preissig S . Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg. 1978; 188(3):377-83. PMC: 1396960. DOI: 10.1097/00000658-197809000-00013. View

Graze K, Spiler I, TASHJIAN Jr A, MELVIN K, Gagel R, Miller H . Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. N Engl J Med. 1978; 299(18):980-5. DOI: 10.1056/NEJM197811022991804. View

Kan Y, DOZY A . Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A. 1978; 75(11):5631-5. PMC: 393021. DOI: 10.1073/pnas.75.11.5631. View

Norton J, Froome L, Farrell R, Wells Jr S . Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979; 59(1):109-18. DOI: 10.1016/s0039-6109(16)41737-8. View

Jackson C, BLOCK M, GREENAWALD K, TASHJIAN Jr A . The two-mutational-event theory in medullary thyroid cancer. Am J Hum Genet. 1979; 31(6):704-10. PMC: 1686035. View

BLOCK M, Jackson C, GREENAWALD K, Yott J, TASHJIAN Jr A . Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. Arch Surg. 1980; 115(2):142-8. DOI: 10.1001/archsurg.1980.01380020012004. View

Deftos L, Weisman M, Williams G, Karpf D, Frumar A, Davidson B . Influence of age and sex on plasma calcitonin in human beings. N Engl J Med. 1980; 302(24):1351-3. DOI: 10.1056/NEJM198006123022407. View

10.

Carney J, Roth S, Heath 3rd H, Sizemore G, HAYLES A . The parathyroid glands in multiple endocrine neoplasia type 2b. Am J Pathol. 1980; 99(2):387-98. PMC: 1903493. View

11.

Webb T, Sheps S, Carney J . Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrime neoplasia, type 2. Am J Surg Pathol. 1980; 4(2):121-6. DOI: 10.1097/00000478-198004000-00003. View

12.

Emmertsen K, Nielsen H, Mosekilde L, Hansen H . Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid. Acta Radiol Oncol. 1980; 19(2):85-9. DOI: 10.3109/02841868009130138. View

13.

Dyck P, Carney J, Sizemore G, Okazaki H, Brimijoin W, LAMBERT E . Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol. 1979; 6(4):302-14. DOI: 10.1002/ana.410060404. View

14.

Roos B, Huber M, Birnbaum R, Aron D, LINDALL A, Lips K . Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin. J Clin Endocrinol Metab. 1983; 56(4):802-7. DOI: 10.1210/jcem-56-4-802. View

15.

Brown M, Allison D, Jenner D, Lewis P, Dollery C . Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet. 1981; 1(8213):174-7. DOI: 10.1016/s0140-6736(81)90058-1. View

16.

Sisson J, Frager M, Valk T, Gross M, Swanson D, Wieland D . Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981; 305(1):12-7. DOI: 10.1056/NEJM198107023050103. View

17.

Riley Jr F, Robertson D . Ocular histopathology in multiple endocrine neoplasia type 2b. Am J Ophthalmol. 1981; 91(1):57-64. DOI: 10.1016/0002-9394(81)90349-4. View

18.

Valk T, Frager M, Gross M, Sisson J, Wieland D, Swanson D . Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med. 1981; 94(6):762-7. DOI: 10.7326/0003-4819-94-6-762. View

19.

Stevenson J, Hillyard C, Spanos E, MacIntyre I, Ackroyd N, Lynn J . Sipple syndrome: marked variability of the disease within a family and implications for management. Postgrad Med J. 1981; 57(664):104-8. PMC: 2424808. DOI: 10.1136/pgmj.57.664.104. View

20.

WOLFE H, DeLellis R . Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab. 1981; 10(2):351-65. DOI: 10.1016/s0300-595x(81)80027-8. View